On the last day of autumn in 2023 (1402), the second Iran Plasma Conference was held with the participation of active members of the plasma industry.
The main focus of this conference was on the critical importance of securing plasma and its derived medications, as well as the vital role these products play in restoring patients’ health.
In the final days of 2023 (1402) and on the eve of the new year, the primary concern of the industry’s stakeholders remains the removal of existing barriers and challenges to the greatest extent possible, ensuring that patients have access to vital plasma-derived products.
We look forward to enhancing technological capabilities within the country and advancing the plasma industry in the coming years.